Arthex Biotech logo

Arthex Biotech

Clinical stage treatment for Myotonic Dystrophy Type 1

2

Funding Rounds

$50.9m

Money raised

Overview

Clinical stage treatment for Myotonic Dystrophy Type 1

Funding

Funding series

Funding Series Analysis

The company Arthex Biotech has raised a total of $50.9m in funding over 2 rounds.

Key Insights:

  • ARTHEx Biotech May 2023 Series B Funding Round: $46m
  • Arthex Biotech , July 2020: $4.9m
Arthex Biotech logo
ARTHEx Biotech May 2023 Series B Funding Round $46m
Arthex Biotech logo
Arthex Biotech , July 2020 $4.9m

Industries

Arthex Biotech is active in the following industries: